TETRA BIO-PHARMA INC

TETRA BIO-PHARMA INC Share · CA88166Y1007 · A2ASQ8 (XTSE) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of TETRA BIO-PHARMA INC
No Price
Share Float & Liquidity
Free Float 98,91 %
Shares Float 418,75 M
Shares Outstanding 423,36 M
Company Profile for TETRA BIO-PHARMA INC Share
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.

Company Data

Name TETRA BIO-PHARMA INC
Company Tetra Bio-Pharma Inc.
Website https://www.tetrabiopharma.com
Primary Exchange XTSE TSX
WKN A2ASQ8
ISIN CA88166Y1007
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Guy Chamberland Master Herbal
Market Capitalization 11 Mio
Country Canada
Currency CAD
Employees 0,0 T
Address 2316 St. Joseph Boulevard, K1C 1E8 Orléans
IPO Date 2018-07-10

Stock Splits

Date Split
23.06.2014 1:2

Ticker Symbols

Name Symbol
TSX TBP.TO
More Shares
Investors who hold TETRA BIO-PHARMA INC also have the following shares in their portfolio:
EIB 21/27 FLR
EIB 21/27 FLR Bond
PICTET-BIOTECH NAM.PDL
PICTET-BIOTECH NAM.PDL Fund